Anne Mcgeorge
Director at Dianthus Therapeutics, Inc. /DE/ (DNTH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $845K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 1,4506,300 held (−19%) | $107.58 | $156K | -23.4% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 2,8003,500 held (−44%) | $108.38 | $303K | -24.0% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 1,8001,700 held (−51%) | $109.30 | $197K | -24.6% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 1,000700 held (−59%) | $110.64 | $111K | -25.6% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 700 | $111.41 | $78K | -26.1% |
- Sell
Director Anne Mcgeorge sold $156K of DNTH at $107.58 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Anne Mcgeorge sold $303K of DNTH at $108.38 — cuts the stake by 44%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Anne Mcgeorge sold $197K of DNTH at $109.30 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Anne Mcgeorge sold $111K of DNTH at $110.64 — cuts the stake by 59%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Anne Mcgeorge sold $78K of DNTH at $111.41 — pre-scheduled 10b5-1 plan sale.